Elevated BMI tracked with lower recent suicide attempts in young men with depression
Among 520 treatment-naïve young adults with major depressive disorder, the relationship between body mass index and recent suicide attempts split along sex lines. In males, overweight or obesity was associated with fewer suicide attempts in the prior 3 months, while no comparable pattern emerged in females. The cohort was limited to patients aged 18 to 25 years, a period when depressive illness, impulsivity, and metabolic change can collide in clinically unstable ways.
The study defined suicide attempt as an event occurring within the past 3 months and paired psychiatric assessment with biochemical testing, including glycemic indices, lipid profiles, and thyroid hormone measures. This design matters because suicidal behavior in depression rarely sits in isolation; endocrine, inflammatory, and metabolic factors often travel with symptom burden and may shape risk in different directions depending on sex, body composition, and illness severity. In this cohort, the prevalence of overweight or obesity did not differ significantly by sex, so the striking separation came from outcomes rather than baseline weight distribution.
A sharp contrast appeared in men. Recent suicide attempts were more common among males without overweight or obesity than among those with elevated BMI, 24.5% versus 12.5%. After adjustment for systolic blood pressure, diastolic blood pressure, thyroid-stimulating hormone, and education level, overweight or obesity remained independently associated with lower odds of suicide attempt in males, with an odds ratio of 0.32, a 95% confidence interval of 0.15 to 0.71, and a P value of 0.005.
The signal did not extend to females. In women, the prevalence of recent suicide attempts was 18.7% in those without overweight or obesity and 15.0% in those with overweight or obesity, a difference that was not statistically significant. The full-sample model also did not support a significant sex × overweight/obesity interaction, with P = 0.24. In practice, that means the sex-stratified patterns are best treated as descriptive observations rather than definitive proof of a biologically distinct interaction.
Symptom severity, thyroid autoimmunity, and anxiety separated the subgroups
The subgroup analyses are the most clinically revealing part of the dataset. Once patients were divided by sex and BMI category, the factors linked to suicide attempts were not the same across groups. In males with overweight or obesity, the Hamilton Depression Rating Scale score was associated with suicide attempts, with an odds ratio of 1.32 and a P value of 0.049. In males without overweight or obesity, age, anxiety burden, and BMI itself carried the strongest associations: age had an odds ratio of 1.73, HAMA score had an odds ratio of 1.91, and BMI had an odds ratio of 0.38.
The pattern in females was different again. Among females with overweight or obesity, the Hamilton Anxiety Rating Scale score was associated with suicide attempts, with an odds ratio of 1.32, and thyroid peroxidase antibody level carried an odds ratio of 2.29 per 1-SD increment. Among females without overweight or obesity, the Hamilton Depression Rating Scale score was associated with suicide attempts, with an odds ratio of 1.38. The appearance of TPOAb in one subgroup is notable because thyroid autoimmunity may mark a broader inflammatory or endocrine vulnerability, especially in a depressive syndrome where sleep disturbance, fatigue, and somatic symptoms can overlap with thyroid-related complaints.
One clinical implication stands out immediately: weight alone cannot be read as protective or harmful in a simple way for suicidal behavior in depressed young adults. The direction and strength of association changed with sex, symptom burden, and endocrine markers. In men, higher BMI aligned with lower odds of recent suicide attempt, but in women the relationship was weaker and statistically absent. The bedside consequence is not to infer safety from body size, but to assess suicidality directly and repeatedly, regardless of weight category.
These findings also fit broader neurobiological ideas without exceeding the data. Adiposity can alter leptin signaling, sex hormone availability, inflammatory tone, and energy balance, all of which may intersect with mood regulation and behavioral inhibition. Yet the same metabolic state may not act identically in young men and women, especially in treatment-naïve patients whose symptoms have not been modified by antidepressants, weight gain from medication, or chronic psychiatric care. The absence of treatment exposure here keeps the phenotype cleaner, but it also leaves open whether the observed association would persist after therapy begins.
The cohort included comprehensive biochemical assessment, but the report stops short of mechanistic proof. No causal pathway can be extracted from a cross-sectional or retrospective association of this type, and the sex × BMI interaction did not meet significance. Still, the data argue for more precise suicide risk stratification in early-stage depression, especially when patients present with different mixtures of weight status, anxiety, depressive severity, and thyroid markers.
A larger, prospectively designed study with formal interaction testing and mechanistic measurements will be needed to determine whether these patterns are reproducible or whether they reflect a cohort-specific snapshot. For now, the most defensible reading is narrower: in treatment-naïve young adults with major depressive disorder, the link between BMI and recent suicide attempts differs across sex-stratified clinical profiles, and the accompanying psychiatric and endocrine correlates are not the same in each subgroup.